Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.
about
VEGF-initiated angiogenesis and the uPA/uPAR systemThe role of vascular actors in two dimensional dialogue of human bone marrow stromal cell and endothelial cell for inducing self-assembled network.Small-molecule inhibition of the uPAR·uPA interaction: synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis.Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cellsUrokinase and its receptors in chronic kidney disease.Effects of HER2 overexpression on cell signaling networks governing proliferation and migration.Targeting multiple conformations leads to small molecule inhibitors of the uPAR·uPA protein-protein interaction that block cancer cell invasionDissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells.HIF-2α Expression Regulates Sprout Formation into 3D Fibrin Matrices in Prolonged Hypoxia in Human Microvascular Endothelial CellsDesign, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor.The tumor microenvironment: key to early detection.The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization.Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury.FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator systemFOXM1 and its oncogenic signaling in pancreatic cancer pathogenesisEndothelium--role in regulation of coagulation and inflammation.Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.Involvement of urokinase-type plasminogen activator system in cancer: an overview.Angiogenesis in cancer: Anti-VEGF escape mechanismsThe NC11 domain of human collagen XVI induces vasculogenic mimicry in oral squamous cell carcinoma cells.Urokinase-type plasminogen activator receptor regulates apoptotic sensitivity of colon cancer HCT116 cell line to TRAIL via JNK-p53 pathway.Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.uPAR: a modulator of VEGF-induced angiogenesis.Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium.The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis.
P2860
Q27025897-E0496EC4-83D1-490F-A705-B8A0858CB4C7Q33815298-0C073447-418A-4314-9495-178D0839D893Q34587758-DE7B007B-1DB4-4C12-BDDD-DAE59DBC68CFQ34924478-E676C89D-7C67-4A20-891A-ABC95C3356C3Q35124141-6471C3E8-A891-4FE5-99D0-DE53DE2DEEB2Q35194023-B632727C-D6FF-4982-ABC6-5B071667F8A3Q35563311-7380188B-ECDA-4B11-8DC1-6D622F68E220Q36080505-959A2AF5-64D3-4370-962D-D6F459E75E6FQ36094681-CAADE7E8-FC58-4F61-A7C6-5871E5AA8534Q36221040-4F90EDBF-03C9-4F7D-A1B8-7C52ED73DE1FQ36627750-27C43E4D-4F71-44C8-9BDE-2A5644A820E3Q36805290-CAF2903F-CC5F-42F5-8CF1-4BDEC3A363FBQ37078600-0DAE6EF3-D223-4AA1-A0E7-A9AEE052C260Q37087120-D6B3393C-E022-4791-ABA5-67BB642C4DF1Q37098900-78539AF6-328E-438C-988A-3C7E8A28C5E3Q37336713-0F91CAFC-B846-4A19-BC6E-050095965CA8Q37374039-4F28741C-228F-4157-B797-66E322A59B05Q37646911-C37C4E54-D6E5-4005-A200-32258AF9699DQ37716906-C14D8ADA-287C-466A-9DD8-E9516B775A07Q37918456-90215299-DEEC-4344-AB41-011612011D7AQ38132176-D5486BAB-74C2-4A82-AA48-E076B1F42353Q38189275-21BD1E82-37D5-4D3B-B4AF-D61694841E02Q38389975-1FC7FE52-4452-4D6F-9BDA-A0343EE700DEQ38831126-2F86049A-3575-450A-B625-1457CFD52D05Q38967029-3337904E-C07C-4C53-8913-4B3102114176Q39747275-82B1DAD5-12DE-48EE-8D3D-91B17171AD95Q39846676-9F0BA2C2-F3AE-4AB4-AD50-644367C42149Q42726309-572365C0-17CA-4512-8E25-7F2F6594A828Q47756936-6BDE9A49-A828-466F-B98A-3622B617941CQ54233643-C3968C35-3CE4-49EA-914F-57A8A93DBF0D
P2860
Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Vascular endothelial growth fa ...... nce of the urokinase receptor.
@en
Vascular endothelial growth fa ...... nce of the urokinase receptor.
@nl
type
label
Vascular endothelial growth fa ...... nce of the urokinase receptor.
@en
Vascular endothelial growth fa ...... nce of the urokinase receptor.
@nl
prefLabel
Vascular endothelial growth fa ...... nce of the urokinase receptor.
@en
Vascular endothelial growth fa ...... nce of the urokinase receptor.
@nl
P2093
P50
P1433
P1476
Vascular endothelial growth fa ...... nce of the urokinase receptor.
@en
P2093
Bernd R Binder
Damla Olcaydu
Gerald W Prager
Judit Mihaly
Stefan Steurer
P304
P356
10.1161/01.RES.0000131498.36194.6B
P577
2004-05-06T00:00:00Z